Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
Clinical trial NCT00686699 · TERMINATED
Trial details
- NCT number
- NCT00686699
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-10
- Primary completion
- 2008-03-06
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.